Leading the Way in Life Science Technologies

GEN Exclusives

More »

Wall Street BioBeat

More »
Apr 1, 2010 (Vol. 30, No. 7)

IP Position Critical to Biotech Investment

Looming Battle over Gene Patenting Could Jeopardize Medical Advances

  • Takeaways: The Case for Gene Patents

    • Gene patents are the foundation of the biotech industry and precluding them would halt forward progress.
    • The patent system promotes innovation and stimulates investment in R&D.
    • If there were no exclusive rights in the final product, there would be
      little incentive to invest time and money into developing it.
    • Without the incentives offered by the issuance of patents, the industry and, ultimately, patients would suffer.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »